HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Gosselin Selected Research

Acetylmuramyl-Alanyl-Isoglutamine

7/2020Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease.
1/2018Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.
1/2012Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Gosselin Research Topics

Disease

16Infections
01/2018 - 05/2002
6Inflammation (Inflammations)
12/2016 - 09/2007
4Virus Diseases (Viral Diseases)
01/2018 - 11/2012
2Multiple Sclerosis
04/2021 - 01/2021
2Encephalitis (Encephalitis, Rasmussen)
12/2018 - 07/2013
2Epstein-Barr Virus Infections
07/2010 - 08/2007
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
07/2020
1Pneumonia (Pneumonitis)
01/2018
1Arthritis (Polyarthritis)
12/2016
1Rheumatoid Arthritis
01/2016
1Human Influenza (Influenza)
01/2015
1Necrosis
12/2011
1MYD88 Deficiency
10/2010
1HIV Infections (HIV Infection)
06/2004

Drug/Important Bio-Agent (IBA)

6Leukotriene B4IBA
01/2015 - 02/2005
5Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2002
4LipidsIBA
01/2014 - 06/2004
3Acetylmuramyl-Alanyl-IsoglutamineIBA
07/2020 - 01/2012
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2016 - 07/2013
2Neuroprotective AgentsIBA
04/2021 - 01/2021
2Therapeutic UsesIBA
01/2021 - 07/2020
2NucleotidesIBA
01/2018 - 01/2015
2cytosporone BIBA
01/2017 - 12/2016
2Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2014 - 02/2005
2Interferon Type IIBA
07/2013 - 07/2010
2CytokinesIBA
10/2010 - 07/2010
2Antiviral Agents (Antivirals)IBA
05/2008 - 09/2007
1CuprizoneIBA
01/2021
1Interferon Regulatory FactorsIBA
12/2018
1Transcription Factors (Transcription Factor)IBA
01/2017
1AntigensIBA
12/2016
1Toll-Like Receptor AgonistsIBA
01/2016
1Antimicrobial PeptidesIBA
01/2015
1Chemotactic FactorsIBA
01/2015
1Phospholipases A2 (Phospholipase A2)IBA
01/2014
1Arachidonic Acid (Vitamin F)IBA
01/2014
1RNA Helicases (RNA Helicase)IBA
07/2013
1LigandsIBA
11/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2011
1Immunoglobulin A (IgA)IBA
12/2011
1Interleukin-6 (Interleukin 6)IBA
10/2010
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1Chloroquine (Aralen)FDA LinkGeneric
09/2010
1Factor VII (Proconvertin)IBA
07/2010
1hemozoinIBA
09/2009
1ChemokinesIBA
08/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2007
1Small Interfering RNA (siRNA)IBA
08/2007
1Pattern Recognition ReceptorsIBA
08/2007
1LeukotrienesIBA
02/2005
1Viral ProteinsIBA
05/2004
1Messenger RNA (mRNA)IBA
04/2003
1Prostaglandins EIBA
08/2002
1IsoenzymesIBA
07/2002
1phorbolIBA
07/2002
1Serine (L-Serine)FDA Link
05/2002
1Threonine (L-Threonine)FDA Link
05/2002

Therapy/Procedure

1Immunomodulation
07/2020